A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies

BACKGROUND: Cancer patients particularly those with hematological malignancies are at higher risk of affecting by severe coronavirus disease 2019 (COVID-19). Due to the immunocompromised nature of the disease and the immunosuppressive treatments, they are more likely to develop less antibody protect...

Descripción completa

Detalles Bibliográficos
Autores principales: Noori, Maryam, Azizi, Shadi, Abbasi Varaki, Farhan, Nejadghaderi, Seyed Aria, Bashash, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273573/
https://www.ncbi.nlm.nih.gov/pubmed/35843148
http://dx.doi.org/10.1016/j.intimp.2022.109046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273573/
https://www.ncbi.nlm.nih.gov/pubmed/35843148
http://dx.doi.org/10.1016/j.intimp.2022.109046

Ejemplares similares